Related Experiment Video
Updated: May 7, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Large vessel giant cell arteritis
Kornelis S M van der Geest1, Maria Sandovici1, Thorsten A Bley2
1Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Insights
Giant cell arteritis primarily affects those over 50. Large vessel giant cell arteritis, impacting the aorta, is often missed and requires advanced imaging for diagnosis and monitoring.
Area of Science:
- Rheumatology
- Internal Medicine
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is the most common systemic vasculitis in individuals over 50.
- Large vessel GCA (LV-GCA) involves the aorta and its branches, potentially occurring with or without cranial GCA.
- LV-GCA often presents with non-specific constitutional symptoms, leading to delayed diagnosis.
Purpose of the Study:
- To define the large vessel subset of giant cell arteritis.
- To summarize the clinical challenges associated with LV-GCA.
- To identify future research directions for LV-GCA management.
Main Methods:
- Review of existing literature and clinical data on LV-GCA.
- Discussion of diagnostic imaging modalities including ultrasonography, MRA, CTA, and PET-CT.
- Analysis of current understanding of LV-GCA presentation and complications.
Main Results:
- LV-GCA is frequently overlooked, necessitating specific imaging for exclusion.
- Imaging (MRA, CTA) is vital for detecting aortic aneurysms during follow-up.
- The role of imaging in treatment monitoring requires further investigation.
Conclusions:
- LV-GCA represents a distinct clinical challenge within GCA.
- Early and accurate diagnosis through advanced imaging is crucial.
- Further research is needed to optimize the management and monitoring of LV-GCA.
Abstract:
Giant cell arteritis is the principal form of systemic vasculitis affecting people over 50. Large-vessel involvement, termed large vessel giant cell arteritis, mainly affects the aorta and its branches, often occurring alongside cranial giant cell arteritis, but large vessel giant cell arteritis without cranial giant cell arteritis can also occur. Patients mostly present with constitutional symptoms, with localising large vessel giant cell arteritis symptoms present in a minority of patients only. Large vessel giant cell arteritis is usually overlooked until clinicians seek to exclude it with imaging by ultrasonography, magnetic resonance angiography (MRA), computed tomography angiography (CTA), or [18F]fluorodeoxyglucose-PET-CT. Although the role of imaging in treatment monitoring remains uncertain, imaging by MRA or CTA is crucial for identifying aortic aneurysm formation during patient follow up. In this Series paper, we define the large vessel subset of giant cell arteritis and summarise its clinical challenges. Furthermore, we identify areas for future research regarding the management of large vessel giant cell arteritis.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Related Concept Videos
Vascular Spasm
Arteries and Arterioles
Arteries of the Upper Limbs
Rheumatic Heart Disease I: Introduction
Peripheral Artery Disease I: Introduction
Chronic Inflammation: Introduction